- Home
- CDIO
as 04-23-2025 4:00pm EST
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 19.5M | IPO Year: | N/A |
| Target Price: | $2.00 | AVG Volume (30 days): | 763.1K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.19 - $1.77 | Next Earning Date: | 05-14-2025 |
| Revenue: | $34,890 | Revenue Growth: | 104.45% |
| Revenue Growth (this year): | 1434.82% | Revenue Growth (next year): | 4661.90% |
Latest Cardio Diagnostics Holdings Inc. Common stock News
CDIO Breaking Stock News: Dive into CDIO Ticker-Specific Updates for Smart Investing
Business Wire
a month ago
Cardio Diagnostics Holdings, Inc. to Showcase Enhanced PrecisionCHD™, Actionable Clinical Intelligence™ and New Clinical Advancements at the American College of Cardiology’s 74th Annual Scientific Session
Simply Wall St.
a month ago
Cardio Diagnostics Holdings Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag
Insider Monkey
2 months ago
Is Cardio Diagnostics Holdings, Inc. (CDIO) The Best Day Trading Stock To Invest In Now?
Insider Monkey
3 months ago
Cardio Diagnostics Holdings, Inc. (CDIO) Expands AI-Driven Heart Disease Testing with 7 New Partnerships
Business Wire
3 months ago
Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations
Insider Monkey
4 months ago
Cardio Diagnostics Holdings, Inc. (CDIO) Secures Medicare Pricing Approval for Precision Cardiovascular Tests
Business Wire
4 months ago
Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests
Simply Wall St.
5 months ago
Cardio Diagnostics Holdings Third Quarter 2024 Earnings: Misses Expectations
Compare CDIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDIO Cardio Diagnostics Holdings Inc. Common stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.